Point72 Asia (Singapore)’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,739
Closed -$130K 1360
2024
Q1
$130K Buy
+4,739
New +$130K 0.03% 566